Overcoming Common Challenges in Fill Finish for Monoclonal Antibodies (mAbs)
Monoclonal antibodies (or mAbs) are class of therapeutic proteins designed to target specific molecules or cells in the body. They are used in treating cancer, autoimmune disorders, and infectious diseases,…
Beyond Lipids: The Science of LNP Manufacturing and Fill Finish
Lipid nanoparticles (LNPs), composed of lipids and encapsulating active pharmaceutical ingredients (APIs), have gained considerable attention due to their ability to overcome bioavailability and stability limitations associated with traditional drug…
Optimizing Oligonucleotide Drug Products: Strategies for Formulation, Lyophilization, and Fill Finish Processes
Imagine if you could create a targeted, highly effective, and life-saving treatment to a disease once thought untreatable and incurable with few to no side effects. That is what the…
